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Summary  29 
Feline coronavirus (FCoV) is transmitted via the faecal-oral route and primarily infects 30 
enterocytes, but subsequently spreads by monocyte-associated viraemia. In some infected 31 
cats, virulent virus mutants induce feline infectious peritonitis (FIP), a fatal systemic disease 32 
that can develop in association with viraemia. Persistently infected, healthy carriers are 33 
believed to be most important in the epidemiology of FIP, since they represent a constant 34 
source of FCoV, either persistently or intermittently shedded in faeces. So far, the sites of 35 
viral persistence have not been determined definitely. The purpose of this study was to 36 
examine virus distribution and viral load in organs and gut compartments of specified 37 
pathogen-free cats, orally infected with non-virulent type I FCoV, over different time periods 38 
and with or without detectable viraemia. The colon was identified as the major site of FCoV 39 
persistence and likely source for recurrent shedding, but the virus was shown to also persist in 40 
several other organs, mainly in tissue macrophages. These might represent additional sources 41 





Feline infectious peritonitis (FIP) is a fatal disease of cats, caused by feline coronavirus 46 
(FCoV). FIP is currently the leading infectious cause of death in cats (Pedersen, 2009). 47 
Despite the generally high prevalence of FCoV infection among the cat population (up to 48 
90% seropositive animals depending on environment and geographical area), FIP morbidity 49 
is low and rarely surpasses 5% of infected cats, mostly affecting young animals (Pedersen, 50 
2009). This is likely due to the fact that FIP only develops with the occurrence of virulent 51 
FCoV mutants, possibly either generated within the individual infected host or externally 52 
aquired (Poland et al., 1996; Vennema et al., 1998; Brown et al., 2009; Chang et al., 2009; 53 
Pedersen et al., 2009). Two FCoV serotypes, I and II, can be distinguished; these show 54 
different geographical prevalence but, so far, no evident differences in their pathogenic 55 
potential (Kummrow et al., 2005; Lin et al., 2009). FCoV is transmitted via the faecal-oral 56 
route and infects primarily enterocytes (Pedersen, 1995). In the scientific literature, two 57 
FCoV biotypes are distinguished, Feline Enteric Coronaviruses (FECV) that are endemic in 58 
cat populations and generally not associated with clinical disease, and FIP viruses (FIPV) that 59 
might arise from endemic FECV either as an in vivo mutation or as virulent strains and are 60 
responsible for the development of FIP (Vennema, 1999; Brown et al., 2009; Chang et al., 61 
2009; Pedersen et al., 2009). Regardless of the development of FIP, however, FCoV spreads 62 
from its initial site of infection within the intestine via monocyte-associated viraemia (Gunn-63 
Moore et al., 1998; Kipar et al., 1999, 2005; Meli et al., 2004) and can replicate within 64 
monocytes in healthy cats (Can-Sahna et al., 2007). The pathogenesis of FIP is not fully 65 
understood, but it has been shown that a monocyte-triggered vasculitis, in association with 66 
systemic monocyte and endothelial cell activation, represents the crucial event (Kipar et al., 67 
2005), likely in combination with some antibody-mediated enhancement and complement 68 
activation (Dewerchin et al., 2006). Cats can be FCoV carriers and commonly remain healthy 69 
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despite systemic infection (Herrewegh et al., 1995; Addie et al., 1996; Gunn-Moore et al., 70 
1998; Kipar et al., 1999; Meli et al., 2004). Previous studies indicate that FCoV persists 71 
within the intestine and is shed persistently or intermittently with the faeces (Foley et al., 72 
1997; Herrewegh et al., 1997; Harpold et al., 1999; Meli et al., 2004). Therefore, persistently 73 
infected, healthy carriers are believed to play the key role in the epidemiology of FIP (Foley 74 
et al., 1997; Meli et al., 2004).  75 
The aim of the present study was to identify the sites of FCoV persistence in healthy carriers. 76 
As FCoV can spread systemically within monocytes, we surmised that the virus could persist 77 
in both intestinal and extra-intestinal sites. To investigate this hypothesis, specified pathogen-78 
free (SPF) cats were experimentally infected via the oral route with high doses of infectious, 79 
non-pathogenic FCoV serotype I field isolates. Cats were examined at different time points, 80 
between 14 and 80 days post infection (p.i.) for viraemia, viral shedding and viral loads as 81 
well as viral antigen in selected organs. 82 
 83 
 84 
Results  85 
 86 
Oral infection with non-virulent FCoV serotype I field strains remains clinically inapparent 87 
but leads to viraemia. 88 
FCoV I is known to be the most common serotype in field cases (Hohdatsu et al., 1992; 89 
Addie et al., 2003; Benetka et al., 2004; Kummrow et al., 2005; Lin et al., 2009). Different 90 
from serotype II FCoV, they hardly grow in tissue culture (Jacobse-Geels & Horzinek, 1983); 91 
however, oral administration of faeces or gut homogenates from shedding cats leads to 92 
intestinal infection and monocyte-associated viraemia (Meli et al., 2004).  93 
For the present study, 30 SPF cats were orally infected with different doses of previously 94 
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described non-virulent FCoV serotype I field strains (FECV biotype) prepared from faeces or 95 
gut homogenates of infected, clinically healthy cats (Acc.-Nos. DQ256137 to DQ256140; 96 
Table 1; Meli et al., 2004). The different virus isolates and infectious doses lead to similar 97 
relative viral loads in all organs tested (see below), as confirmed by an ANOVA comparison. 98 
Viraemia was confirmed by FCoV real-time RT-PCR, performed weekly and at the time of 99 
euthanasia on whole blood, plasma and/or monocytes (Meli et al., 2004). Viraemia was 100 
detected one week p.i., and most cats (20/30; 67%) were positive at one to several, often not 101 
consecutive time points, with a peak at day 7 p.i. (14/30; 47%) and decline thereafter (day 14 102 
p.i.: 12/30 (40%), day 17 p.i.: 4/28 (14%), day 28 p.i.: 1/25 (4%), day 35 p.i.: 1/21 (5%), day 103 
42 p.i.: 0/21, day 48 p.i.: 3/21 (14%); days 58, 65 and 80 p.i.: 0/6). No cat proved to be 104 
viraemic over the entire test period, but three showed recurrent viraemia. A total of four cats 105 
were viraemic at the time of death (day 17 p.i. (n=1), day 48 p.i. (n=3), 13.3%). There were 106 
no differences in the course and level of viraemia depending on virus isolate or infectious 107 
doses. These results show that the virus isolates generally lead to viraemia within a week 108 
after infection, which can recur at later time points.   109 
Cats were necropsied and examined grossly and histologically to identify any potential 110 
pathological effects of the infection. There were no changes indicative of feline infectious 111 
peritonitis (FIP; Kipar et al., 2005). Histological findings were restricted to moderate 112 
lymphatic hyperplasia in spleen and mesenteric lymph nodes, some degree of lymph node 113 
sinus histiocytosis, none or minimal thymic involution and moderate to high bone marrow 114 
activity. This was consistent with previous findings in clinically healthy, FCoV infected cats 115 
and confirms that FCoV infection induces an intense systemic immune response (Kipar et al., 116 
1999, 2001; Meli et al., 2004). 117 
 118 
After oral infection FCoV can spread to all organs and persist in the absence of detectable 119 
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viraemia. 120 
Having confirmed that oral infection did generally induce viraemia, we wanted to assess 121 
i) whether all intestinal compartments become infected and where in the gut the virus 122 
persists, and ii) whether the virus establishes itself in other organs. For this purpose, we 123 
performed FCoV real-time RT-PCR on a large range of tissues (see below) collected 124 
immediately after death, a time when only four cats (13.3%) were confirmed to be viraemic. 125 
FCoV RNA was detected in organs of all animals. All organs were positive, regardless of 126 
detectable viraemia, in at least some cats (181 positive samples; 41.9%), with the following 127 
frequency: colon 28 (15.5%), liver 21 (11.6%), mesenteric lymph nodes 19 (10.5%), ileum 14 128 
(7.7%), thymus 13 (7.2%), jejunum 12 (6.6%), kidney 12 (6.6%), tonsil 11 (6.1%), lung 11 129 
(6.1%), spleen 10 (5.5%), duodenum 9 (5.0%), bone marrow 8 (4.4%), brain 6 (3.3%), skin 5 130 
(2.8%) and skeletal muscle 2 (1.1%) (Fig. 1). Overall, the colon tested positive significantly 131 
more frequently than any other tissue. The liver was positive significantly more often than all 132 
other organs, except the mesenteric lymph nodes. The frequency of a test positive organ or 133 
tissue outside the alimentary tract and the lymphatic tissues was as follows: liver 64% 134 
(16/25), kidney 40% (10/25), lung 36% (9/25), brain 20% (5/25), skin 22% (4/18) and 135 
skeletal muscle 11% (2/18). These findings confirm that FCoV can infect the entire intestine, 136 
but indicate the colon as the main site of viral persistence. They also show that FCoV 137 
viraemia generally leads to widespread organ infection and viral persistence in organs and 138 
tissues when virus cannot be detected in the blood.  139 
 140 
Viral shedding is consistent in the early phase of infection and seen with infection of several 141 
intestinal compartments; the colon is the main site of viral persistence.    142 
Having found evidence of viral persistence within the intestine, we wanted to identify any 143 
possible association with viral shedding and tested faecal samples from all cats by FCoV 144 
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PCR over the time periods between infection and death (Meli et al., 2004). All animals 145 
started to shed on day 2 or 3 p.i. and shed relatively consistently up to day 17, followed by 146 
intermittent shedding (data not shown). Independent of the level of viral shedding, the cats 147 
remained clinically healthy, confirming the FCoV isolates as non-pathogenic FECV biotypes. 148 
Also, virus isolates and infectious dose did not have any effect on onset and duration of viral 149 
shedding (Meli et. al 2004).  150 
At the time of death, all cats euthanased at days 14, 17 and 28 p.i. did shed virus. On days 151 
14 and 17 p.i., colon and ileum were always positive, duodenum and jejunum each in most 152 
(4/5) cats. On day 28 p.i., duodenum, ileum and colon were always positive, jejunum in most 153 
(3/4) cats.  On day 48 p.i., cats did not shed virus. Duodenum, jejunum and ileum were only 154 
positive in one, two and three of the 15 cats, respectively, but the colon yielded a positive 155 
result in 14 cats. On day 80, 50% (3/6) of cats did shed virus. While the duodenum was 156 
always negative, the jejunum was positive in three, the ileum in two and the colon in five of 157 
the six cats. One cat tested negative in the entire intestine. Comparison of relative viral loads 158 
in each intestinal compartment over the entire study identified the significantly highest loads 159 
in the colon on day 14 (Fig. 2B), and in jejunum and ileum on day 17. 160 
We looked at the association between viral shedding and the presence of viral RNA in the 161 
different intestinal compartments at the time of death (Table 2). From the 12 cats that 162 
exhibited FCoV RNA only in the colon, only the one with the highest relative viral load was 163 
shown to shed virus. When the colon plus at least two small intestinal compartments were 164 
positive, most cats (8/10) did shed virus. The two non-shedders (day 28 and day 48 p.i., 165 
respectively) even tested positive in all intestinal compartments, but with relatively lower 166 
overall intestinal viral loads than the five shedding animals that showed viral RNA in all 167 
intestinal compartments.  168 
Overall, relative viral loads in the colon were significantly higher (on average 1.66 x 104 169 
 8
[range: 11 – 1.3 x 105] fold higher) than in any other organ; on average 122 [range: 11 - 327] 170 
fold higher than in the other intestinal compartments. Also, there was a significant difference 171 
between positive and negative faecal shedders in terms of the cumulative viral intestinal load, 172 
whereby cats that were found to shed virus had, on average, ten times higher cumulative viral 173 
loads than cats that did not shed.  174 
The results indicate that oral FCoV uptake leads to initial infection of all intestinal 175 
compartments. The virus is cleared frequently from all compartments but the colon at the 176 
later stages (Fig. 1) which confirms the colon as the main site of virus persistence and the 177 
source of recurrent shedding. However, virus spread to and colonisation of the small intestine 178 
appears to be essential for viral shedding, even when the colon exhibits relatively high viral 179 
loads.    180 
 181 
At different time points post infection, the range of organs that harbour FCoV varies. 182 
Having identified FCoV in a wide range of organs in infected cats, we evaluated whether 183 
the extent and pattern of organ infection varied over time (Fig. 1). Overall, colon, liver and 184 
mesenteric lymph nodes were positive with the highest frequency at any time point. 185 
Cats examined on days 14, 17 and 28 p.i. all exhibited systemic infection since FCoV 186 
RNA was demonstrated in several organs. On days 14 (n=2) and 17 (n=3), 6 to 11 of the 13 187 
organs tested were positive (average: 70.8%), with intestines and mesenteric lymph nodes 188 
positive in all cats. On day 28 (n=4), 8to 12 of the 13 organs were positive (average: 73.1%).  189 
On day 48 (n=15), the number of positive organs had significantly dropped (average: 190 
26.2%; 1 to 10 of 15). In one cat, only the colon was positive, at that time point without 191 
detectable viraemia; thus, this cat was most likely not systemically infected at this stage, 192 
although it had been viraemic on days 7 and 14 p.i. (data not shown).  193 
On day 80 (n=6), the number of organs harbouring virus increased again (average: 194 
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42.2%; 3 to 10 of 15). The one cat which did not harbour virus in its intestine (see above) was 195 
nonetheless systemically infected, since tonsils, lung and kidney were positive. 196 
These results show that oral FCoV infection with non-pathogenic strains leads to 197 
viraemia and subsequent persistent systemic infection in the absence of detectable viraemia. 198 
There was no distinct organ infection pattern or a correlation between the number and 199 
distribution of positive organs and the presence of viraemia. The higher number of FCoV 200 
positive organs at day 80 p.i. compared to day 40 p.i. indicates that organs can become re-201 
infected with recurrent viraemia. In general, however, at later time points (days 48 and 80 202 
p.i.), colon, liver, mesenteric lymph nodes and tonsils were the organs positive with the 203 
highest frequency (Fig. 1).  204 
 205 
Organs exhibit highest relative viral loads at earlier time points after infection but can 206 
remain persistently infected for a longer period. 207 
The presence of FCoV in organs without detectable viraemia indicates that the virus can 208 
infect and persist in other cells apart from monocytes and enterocytes. As a basis to identify 209 
candidate host cells, we identified the organs with the relative highest viral loads by means of 210 
FCoV real-time RT-PCR. In general, average relative viral loads varied considerably (Fig. 211 
2A). However, there were significant differences in overall relative viral loads between the 212 
different time points after infection (14, 17, 28, 48 and 80 days p.i.; p = 0.002) and Tukey's 213 
grouping for multiple comparisons identified significant differences in cats euthanized at 214 
days 14 and 17 compared to other time points, but not significantly different from each other. 215 
Thus, there was a trend for higher viral recoveries at 14 and 17 days p.i. compared to the later 216 
time points. For example, viral recoveries at day 14 were on average 41 (range: 1.1 – 152) 217 
fold higher than at other time points. Day 17 viral recoveries were 49 (range: 3.9 – 138) fold 218 
higher than days 28, 48 and 80 recoveries.   219 
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There were significant differences between viral recovery and the organ examined 220 
(p<0.001). Particularly, the colon and jejunum showed significantly higher viral recoveries 221 
than all other organs but not from each other. When the jejunum with a particularly high viral 222 
load (day 17 p.i.) was excluded the colon showed the significantly highest loads. An organ 223 
group comparison on the lymphatic tissues revealed a significantly higher relative viral load 224 
in mesenteric lymph nodes compared to other lymphatic tissues [e.g. spleen (p = 0.021; 25-225 
fold higher), tonsil (p = 0.017; 74-fold higher), thymus (p = 0.016; 146-fold higher)]. These 226 
findings indicate viral spread from the intestine to the regional lymph nodes via the 227 
lymphatics, with only limited further spread. No other organ group comparison revealed 228 
significant differences. Relative viral loads within the liver, which was the organ with the 229 
second highest frequency of test positives, were not particularly high, and on average lower 230 
than, for example, in the lungs (9.3-fold lower) (Fig. 2A).  231 
We compared relative viral loads in selected organs (liver, mesenteric lymph nodes, 232 
lung) and the colon over time. Relative viral loads in the colon and liver were significantly 233 
highest on day 14. For the mesenteric lymph nodes, day 14 displayed significantly higher 234 
viral loads than days 48 and 80, but not days 17 and 28 (Fig. 2B). The lung showed no 235 
significant differences in viral loads over time. These results reveal a general peak in organ 236 
virus loads in the first weeks after infection and ebbing off with time, similar to the intestine.  237 
 238 
Viral persistence is mediated by columnar epithelial cells in the colon and tissue 239 
macrophages in other organs. 240 
FCoV is known to infect intestinal epithelial cells (Pedersen, 1983; Herrewegh et al., 241 
1997; Kipar et al., 1998). In an attempt to identify the cells in which FCoV persist in the gut, 242 
we performed immunohistology for FCoV antigen (Kipar et al., 1998, 2005) on all intestinal 243 
compartments (FCoV-RNA-positive or -negative) of the 15 cats euthanized at day 48 p.i. 244 
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without evidence of virus shedding. FCoV antigen was detected in epithelial cells of the 245 
colon in two animals. Staining was restricted to several columnar epithelial cells on the 246 
mucosal surface in one animal (Fig. 3A) and a single columnar epithelial cell on the mucosal 247 
surface of the second. In both cats the colon had been the only intestinal compartment tested 248 
positive for FCoV RNA, with comparatively high relative viral loads. These results confirm 249 
the colonic columnar epithelial cells as the site of viral persistence in the intestine of non-250 
shedding cats.  251 
Circulating monocytes mediate FCoV viraemia and are responsible for the granulomatous 252 
vasculitis and focal granulomatous lesions in organs that are characteristic for FIP and 253 
harbour virus in macrophages (Kipar et al., 2005). Having demonstrated viral RNA in organs 254 
regardless of detectable viraemia, we hypothesised that the virus can also infect resident 255 
tissue macrophages and performed immunohistology for FCoV antigen on some tissues that 256 
had exhibited comparatively high relative virus loads or were consistently FCoV RNA-257 
positive, the mesenteric lymph nodes since they drain the intestines, as well as liver and lung, 258 
which both contain specific tissue macrophages in constant contact with blood, i.e. hepatic 259 
Kupffer cells and pulmonary intravascular macrophages (Brain et al., 1999; Bilzer et al., 260 
2006). FCoV antigen was detected in several sinus macrophages in the mesenteric lymph 261 
nodes with the highest relative viral load (day 28 p.i.), in association with intense sinus 262 
histiocytosis with several macrophage aggregates (Fig. 3B). In those with the 2nd and 4th 263 
highest viral loads (day 14 and 17 p.i. respectively), each one sinus macrophage was found to 264 
express viral antigen. All three cats exhibited high viral loads within all intestinal 265 
compartments and virus shedding which suggests virus uptake by macrophages in the 266 
intestine and subsequent transport to the regional lymph nodes. Among the three examined 267 
lungs was one (day 28 p.i.), where viral antigen was observed in scattered pulmonary 268 
intravascular macrophages (Fig. 3C). FCoV antigen was not demonstrated in the livers, 269 
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suggesting that the amount of virus per cell was too low to be detected by immunohistology, 270 




The present study investigated SPF cats that had been orally infected with high doses of 275 
non-virulent FCoV type I field strains, for evidence of systemic viral infection, virus 276 
persistence and viral shedding in relation to viraemia over a period of up to 80 days after 277 
infection.  278 
All animals remained clinically healthy. Initially, viral RNA was found in all intestinal 279 
compartments, the blood and several organs of most animals, confirming viraemic spread and 280 
systemic infection.  281 
In the intestine FCoV was detected most consistently and at highest levels in the colon. 282 
Virus shedding, however, was generally observed when both colon and small intestine 283 
harboured virus, with significantly higher cumulative intestinal viral loads, and in the early 284 
phase after infection. It was occasionally seen also at later time points and in cats with 285 
recurrent shedding. These findings suggest that the virus persists in the colon from which it 286 
can re-infect the small intestine at any time. The immunohistological demonstration of viral 287 
antigen within columnar epithelial cells in the colon of cats that did not shed virus, but 288 
harboured FCoV RNA in the intestine confirms the colonic enterocytes as the major site of 289 
FCoV persistence in the gut (Herrewegh et al., 1997). Presence of viral antigen in intestinal 290 
epithelial cells without evidence of cell loss and faecal shedding suggests that non-virulent 291 
FCoV persist by establishing a non-lytic infection in epithelial cells, different from FCoV that 292 
induce enteritis in cats with enterocyte degeneration (Kipar et al., 1998). With regard to 293 
persistence in epithelial cells, FCoV shows similarities to foot-and-mouth disease virus and 294 
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Coxsackievirus B3 (Harrath et al., 2004; Zhang & Alexandersen, 2004). The question arises 295 
as to how the colonic columnar epithelium remains infected, considering that viral antigen 296 
appears only to be present in the superficial epithelium, which is sloughed off in the course of 297 
normal epithelial turnover, and not within replicating cells. Cell-to-cell spread between 298 
epithelial cells may be the mode of transmission to ensure persistence. Furthermore, the 299 
mechanism of FCoV entry into monocytes/macrophages within the gut has so far not been 300 
identified, or if it occurs within specific intestinal compartments. The latter seems unlikely 301 
since resident macrophages are generally numerous throughout the intestine (Platt & Mowat, 302 
2008). 303 
The mesenteric lymph nodes were shown to frequently harbour FCoV RNA, and at 304 
relatively high levels. Considering that some also exhibited viral antigen within sinus 305 
macrophages, it appears very likely that virus from enterocytes is taken up by macrophages in 306 
the intestinal mucosa and is transported to the regional lymph nodes. From there, further 307 
spread via the lymphatics and ultimately the blood, as a potential additional mode of viral 308 
distribution, is possible.  309 
We also identified FCoV RNA in a large range of organs and tissues, which must be a 310 
consequence of systemic viral spread via the blood, i.e. monocyte-associated viraemia, at 311 
some point. In viraemic cats, organs could harbour viral RNA in infected monocytes within 312 
the vasculature. In addition and in the absence of detectable viraemia, however, infection of 313 
parenchymal cells and/or resident macrophages has to be considered. Previous in vitro studies 314 
showed that FCoV can infect specialised macrophages, such as peritoneal macrophages 315 
(Stoddard & Scott, 1989). Indeed, we were able to identify viral antigen in scattered 316 
pulmonary intravascular macrophages (PIM) in a non-viraemic cat with a relatively high viral 317 
titre in the lung. PIM, like hepatic Kupffer cells (HKC) are bone marrow derived 318 
macrophages that form part of the mononuclear phagocyte system. They are resident 319 
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macrophages anchored to endothelial cells within pulmonary capillaries. Together with HKC, 320 
the resident macrophages of the liver that adhere to endothelial cells in the sinusoids, PIM 321 
have been shown in cats to be the main cells to rapidly phagocytose particles carried in the 322 
blood (Brain et al., 1999). PIM have been identified as target cells for viruses, such as 323 
classical swine fever virus, porcine reproductive and respiratory syndrome virus and African 324 
Horse Sickness virus, in acute infections (Thanawongnuwech et al., 1997; Carrasco et al., 325 
1999, 2001), while HKC can become infected with human and feline immunodeficiency virus 326 
and African swine fever virus (Bingen et al., 2002; Ciborowski & Gendelman, 2006; 327 
Sanchez-Cordon et al., 2008). Although we were not able to demonstrate FCoV antigen 328 
within HKC, HCK may be responsible for the presence of FCoV RNA in the liver 329 
particularly of non-viraemic cats. This is supported by a previous study which provided 330 
ultrastructural evidence of FCoV in HKC in cats that had developed FIP after intra-peritoneal 331 
application of highly virulent FIPV (Pedersen, 1976). Consequently, PIM and HKC could 332 
represent sources of recurrent viraemia in FCoV infected cats, via release of virus into the 333 
blood and/or transmission to monocytes. In acute African swine fever, PIM have been shown 334 
to become activated (Carrasco et al., 2002) and it needs to be determined whether in FCoV 335 
infection PIM, due to their location in pulmonary capillaries, can contribute directly to the 336 
development of the granulomatous vasculitis that is often seen in the lung in cats with FIP 337 
(Kipar et al., 2005). 338 
FCoV was demonstrated in all organs/tissues tested both in viraemic cats and cats without 339 
detectable viraemia. The number of infected organs and overall viral loads were significantly 340 
higher in the early phase after infection (days 14 and 17). However, over time, most animals 341 
remained systemically infected and FCoV persisted in several organs, although in a more 342 
sporadic manner and with evidence of re-infection in the course of intermittent viraemia. The 343 
latter is a well known feature of FCoV infection (Foley et al., 1997a; Herrewegh et al., 1997; 344 
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Harpold et al., 1999; Meli et al., 2004) and is also suggested by our real-time RT-PCR results 345 
on the blood. Alternatively, infected cats might exhibit highly variable blood viral loads over 346 
time which drop below detection levels in several cases. In the present study, beside the 347 
mesenteric lymph nodes, the liver was shown to harbour the virus most frequently and at 348 
comparatively high levels. This finding is not surprising considering that the liver directly 349 
drains the blood from the intestines via the portal vein. Also, HKC, should they indeed 350 
become infected with FCoV, are very numerous in the liver and represent 80-90% of tissue 351 
macrophages in the body (Bilzer et al., 2006), which renders them a potential source of high 352 
viral burdens in the liver. The presence of FCoV RNA in tissues without specialised vessel-353 
associated resident macrophages, such as the skeletal muscle, the brain or the skin, in non-354 
viraemic cats cannot readily be explained. However, circulating monocytes have been shown 355 
to leave the blood stream and differentiate to a large proportion into long-lived tissue 356 
macrophages (Randolph et al., 1999). It might therefore be possible that FCoV-infected 357 
monocytes migrate into any tissue where they then differentiate into (persistently infected) 358 
resident macrophages.  359 
 In conclusion, our data identifies the colon as the major site of FCoV persistence and 360 
provides convincing evidence that the differentiated columnar epithelial cell is the target cell 361 
of persistence. However, our results also identify other organs/tissues as sites of persistent 362 
infection and potential sources for recurrent viraemia. Organs with specialised resident 363 
macrophages that either directly drain the gut, such as the mesenteric lymph nodes, or serve 364 
to filter the blood, such as liver (HKC) and lung (PIM), are the main candidates for this. 365 
These findings imply that clearance of the virus from the gut does not necessarily protect 366 
FCoV-infected cats from recurrent viraemia and, ultimately, the development of FIP at some 367 






Virus preparation 373 
For experimental infections, FCoV serotype I field strains isolated from faecal samples of 374 
naturally infected cats (FCoVZu1 (Acc. No. DQ256137), FCoVZu2 (Acc. No. DQ256138), 375 
FCoVZu3 (Acc. No. DQ256139) and FCoVZu5 (Acc. No. DQ256140)) or from the intestines 376 
(gut homogenates) of cats experimentally infected with FCoVZu1 (NCBI Acc. No. 377 
DQ256137) were used. All isolates have been shown to have similar effects with regard to 378 
infectivity, induction and rate of viral shedding, development of viraemia and pathological 379 
effects (Meli et al., 2004). 380 
Briefly, faecal samples were prepared by dilution in RPMI 1640 medium containing L 381 
glutamine and 10% fetal calf serum, incubation for 10 min at 4°C with occasional shaking, 382 
and centrifugation (2 x 10 min at 900 x g). Gut homogenates were prepared from snap-frozen 383 
intestinal segments of kittens experimentally infected with the FCoVZu1 strain, using an 384 
Ultra Tourax instrument (Kinematica AG, Lucerne, Switzerland) at 20,000 rpm for 15 min at 385 
5-6 intervals. Faecal supernatants and intestinal homogenates were analysed to determine the 386 
FCoV load (RNA copy numbers; see below; Meli et al., 2004). 387 
 388 
Animals 389 
In total, 30 specified pathogen-free (SPF) kittens were provided by IFFA-Credo (Saint-390 
Germain sur l’Arbresle, France) or Liberty Research Labs (Waverly, NY, USA) at either six 391 
or 16 weeks of age. The animals were first acclimatized by keeping them together for four 392 
days and later separated into groups (Table 1). After infection, all cats underwent daily 393 
clinical examinations. At the end of each experiment, all animals were euthanized and 394 
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necropsied within two hours after death. 395 
 396 
Experimental infection 397 
Experimental studies were officially approved by the Swiss veterinary office (66/2000). Cats 398 
were kept in groups under optimal ethological conditions. Each animal was infected per-399 
orally twice within 24 h, under anaesthesia, by application of 2 ml of the total infectious dose 400 
using an oesophageal tube. Different virus isolates, infection doses and formulations were 401 
used (Table 1). 402 
 403 
Sample preparation for determination of viraemia, faecal shedding and viral loads 404 
Viral shedding was identified from purified viral RNA extracted from faecal samples 405 
collected during the examination period and immediately after death. Viraemia was detected 406 
from purified viral RNA extracted from whole blood (cats infected for 14, 17, 21 and 28 407 
days) and monocytes (cats infected for 48 days) every 7th day p.i. and the day of euthanasia as 408 
described previously (Meli et al., 2004).  409 
For RNA isolation from tissues, samples were collected from the duodenum, jejunum, 410 
ileum, colon, mesenteric lymph nodes, liver, spleen, bone marrow, kidney, thymus, lung, 411 
tonsil and brain (frontal cortex), as well as from skin and skeletal muscle (cats euthanased 48 412 
and 80 days p.i. only), under sterile, RNase-free conditions and frozen directly in liquid 413 
nitrogen. The tissues were then stored at -80°C. RNA was purified starting with about 30 mg 414 
of frozen tissue by means of the ABI Prism™ 6700 Automated Nucleic Acid Workstation 415 
(Applied Biosystems (ABI), Rotkreuz, Switzerland) (Meli et al., 2004). As a control for the 416 
efficacy of RNA purification, the RNA was reverse transcribed using the High Capacity 417 
cDNA Archive Kit (Applied Biosystems) and the expression of the housekeeping gene 418 
glyceraldehyd-3-phosphate-dehydrogenase (GAPDH) was measured by real-time PCR 419 
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(Leutenegger et al., 1999).  420 
 421 
Tissue processing for histological examination 422 
At necropsy, samples were collected from the duodenum, jejunum, ileum, caecum (with 423 
caecal lymph nodes), colon, rectum, spleen, mesenteric lymph nodes, tonsils, bone marrow 424 
and thymus as well as liver, kidneys, lung and brain. Tissues were fixed in 10% non-buffered 425 
formalin and routinely embedded in paraffin wax. Sections (3-5 μm) were cut and stained 426 
with haematoxylin-eosin or processed for immunohistological examination. 427 
 428 
Determination of viral loads 429 
Relative FCoV viral loads were determined by one-tube real-time RT-PCR, using an 430 
automated fluorometer (TaqMan, ABI 7700, Applied Biosystems) to detect a 102 bp 431 
fragment of the conserved FCoV 7b gene (Gut et al., 1999). The measured expression of the 432 
house-keeping gene GAPDH was used to normalize the extracted RNA to the same cell 433 
number in all samples and the viral loads were recalibrated to the GAPDH content in the 434 
respective tissues. For samples where an FCoV signal was not observed after 45 cycles, a 435 
plausible viral load was created. This value was ascertained from the lowest RNA signal for 436 
GAPDH found in this study. Thus, a test result in an organ was defined as positive with a 437 
viral load value of > 0.000000000027776. 438 
The infectious doses for the experimental infection were calculated as the RNA copy number 439 
present in the volume of the infectious inoculum given to the cats (Table 1). RNA copy 440 
number was determined based on a standard RNA template (Gut et al., 1999). 441 
 442 
Immunohistological demonstration of FCoV antigen in tissues 443 
The intestines (duodenum, jejunum, ileum, caecum, colon, and rectum) from cats euthanized 444 
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at day 48 p.i. (5.1-5.15) and the seven livers (cats 1.1 and 1.2 (day 14 p.i.), 3.1 and 4.2 (day 445 
28 p.i.), 5.4, 5.14 and 5.15 (day 48 p.i.)), ten mesenteric lymph nodes (cats 1.1 and 1.2 (day 446 
14 p.i.), 2.1 - 2.3 (day 17 p.i.), 3.1, 4.1 and 4.2 (day 28 p.i.), 5.4 and 5.14 (day 48 p.i.)) and 447 
three lungs (cats 1.1 (day 14 p.i.), 2.3 (day 17 p.i.) and 4.1 (day 28 p.i.)) with the highest 448 
relative FCoV viral loads were examined for the presence of FCoV antigen by 449 
immunohistology, using a mouse monoclonal antibody (clone FCV3-70, Custom 450 
Monoclonals Int., West Sarcramento, USA) as described previously (Kipar et al., 1998, 1999, 451 
2001, 2005). 452 
 453 
Statistical analysis 454 
All statistics were performed using SAS 9.1 computer software (SAS Institute, Cary, NC, 455 
USA). Statistical associations were explored between the viral loads in cats after infection 456 
and characteristics of the experiment (e.g. dose of virus, viral load in organs and days from 457 
challenge to euthanasia). Initial assessment of the data was done using descriptive statistics. 458 
Comparisons between the two groups of cats were done using a Mann-Whitney test with 459 
unpaired ties. Comparisons between organs (i.e. more than two groups) were done using a 460 
Kruskal-Wallis analysis of variance. For instances of four or more group comparisons, then 461 
an additional statistical test (e.g. two-way analysis of variance and multiple comparisons 462 
using Tukey’s test for unequal groups) was also employed and results were compared. 463 
Comparisons between the frequency of positive organs was performed using a Fisher’s exact 464 
test. The exact p-values for all non-parametric statistics were calculated using Monte Carlo 465 





The authors would like to gratefully acknowledge Armin Rüdimann, Claudia Müller, 470 
Karoline Jenal and Nicole Borel for expert assistance with the cats as well as Enikö Gönczi, 471 
Edith Rhiner, Elizabeth Rogg, Beatrice Weibel and Anne Griffiths for excellent technical 472 
support. They are grateful to Prof James P Stewart, University of Liverpool, for expert advice 473 
and discussions. The study was performed using the logistics of the Centre for Clinical 474 
Studies at the Vetsuisse Faculty of the University of Zurich and the Histology Laboratory, 475 




Addie, D.D., Toth, S., Herrewegh, A.A. & Jarrett, O. (1996). Feline coronavirus in the 
intestinal contents of cats with feline infectious peritonitis. Vet Rec 139, 522-523. 
Addie, D.D., Schaap, I.A.T., Nicolson, L. & Jarrett, O. (2003). Persistence and 
transmission of natural type I feline coronavirus infection. J Gen Virol 84, 2735-2744. 
Benetka, V., Kubber-Heiss, A., Kolodziejek, J., Nowotny, N., Hofmann-Parisot, M. & 
Mostl, K. (2004). Prevalence of feline coronavirus types I and II in cats with 
histopathologically verified feline infectious peritonitis. Vet Microbiol 99, 31-42. 
Bilzer, M., Roggel, F. & Gerbes, A.L. (2006). Role of Kupffer cells in host defense and 
liver disease. Liver Int 26, 1175-1186. 
Bingen, A., Nonnenmacher, H., Bastien-Valle, M. & Martin, J.-P. (2002). Tissues rich in 
macrophagic cells are the major sites of feline immunodeficiency virus uptake after 
intravenous inoculation into cats. Microbes Infect 4, 795-803. 
Brain, J.D., Molina, R.M., deCamp, M.M. & Warner, A.E. (1999). Pulmonary 
intravascular macrophages: their contribution to the mononuclear phagocyte system in 13 
species. Am J Physiol Lung Cell Mol Physiol 276, 146-154. 
Brown, M.A., Troyer, J.L., Pecon-Slattery, J., Roelke, M.E. & O'Brien, S.J. (2009). 
Genetics and pathogenesis of feline infectious peritonitis virus. Emerg Infect Dis 15, 1445-
1452. 
Can-Sahna, K., Ataseven, V.S., Pinar, D. & Oğuzoğlu, T.C. (2007). The detection of 
feline coronaviruses in blood samples from cats by mRNA RT-PCR. J Fel Med Surg 9, 369-
372. 
Carrasco, L., Sanchez, C., Gomez-Villamandos, J.C., Salguero, F.J., Bautista, M.J., 
Martinez-Torrecuadrada, J., Sanchez-Vizcaino, J.M. & Sierra, M.A. (1999). The role of 
pulmonary intravascular macrophages in the pathogenesis of African Horse Sickness. J Comp 
 22
Path 121, 25-38. 
Carrasco, L., Ruiz-Villamor, E., Gomez-Villamandos, J.C., Salguero, F.J., Bautista, 
M.J., Macia, M., Quezada, M. & Jover, A. (2001). Classical swine fever: morphological 
and morphometric study of pulmonary intravascular macrophages. J Comp Path 125, 1-7. 
Carrasco, L., Nunez, A., Salguero, F.J., Diaz San Segundo, F., Sanchez-Cordon, P., 
Gomez-Villamandos, J.C. & Sierra, M.A. (2002). African swine fever: expression of 
interleukin-1 alpha and tumour necrosis factor-alpha by pulmonary intravascular 
macrophages. J Comp Path 126, 194-201. 
Chang, H.W., de Groot, R.J., Egberink, H.F. & Rottier, P.J. (2009). Feline infectious 
peritonitis; insights into feline coronavirus pathobiogenesis and epidemiology based on 
genetic analysis of the viral 3c gene. J Gen Virol 2009 Nov 4. [Epub ahead of print]. 
Ciborowski, P. & Gendelman, H.E. (2006). Human immunodeficiency virus - mononuclear 
phagocyte interactions: emerging avenues of biomarker discovery, modes of viral persistence 
and disease pathogenesis. Curr HIV Res 4, 279-291. 
Dewerchin, H.L., Cornelissen, E. & Nauwynck, H.J. (2006). Feline infectious peritonitis 
virus-infected monocytes internalize viral membrane-bound proteins upon antibody addition. 
J Gen Virol 87, 1685-1690. 
Foley, J.E., Poland, A., Carlson, J. & Pedersen, N.C. (1997). Patterns of feline coronavirus 
infection and fecal shedding from cats in multiple-cat environments. J Am Vet Med Assoc 
210, 1307-1312. 
Gunn-Moore, D.A., Gruffydd-Jones, T.J. & Harbour, D.A. (1998). Detection of feline 
coronaviruses by culture and reverse transcriptase-polymerase chain reaction of blood 
samples from healthy cats and cats with clinical feline infectious peritonitis. Vet Microbiol 
62, 193-205. 
Gut, M., Leutenegger, C.M., Huder, J.B., Pedersen, N.C. & Lutz, H. (1999). One-tube 
 23
fluorogenic reverse transcription-polymerase chain reaction for the quantitation of feline 
coronaviruses, J Virol Meth 77, 37-46. 
Harpold, L.M., Legendre, A.M., Kennedy, M.A., Plummer, P.J., Millsaps, K. & 
Rohrbach, B. (1999). Fecal shedding of feline coronavirus in adult cats and kittens in an 
Abyssinian cattery. J Am Vet Med Assoc 215, 948-951. 
Harrath, R., Bourlet, T., Delezay, O., Douche-Aourik, F., Omar, S., Aouni, M. & 
Pozzetto, B. (2004). Coxsackievirus B3 replication and persistence in intestinal cells from 
mice infected orally and in the human CaCo-2 cell line. J Med Virol 74, 283-290. 
Herrewegh, A.A.P.M., de Groot, R.J., Cepica, A., Egberink, H.F., Horzinek, M.C. & 
Rottier, P.J. (1995). Detection of feline coronavirus RNA in feces, tissues, and body fluids 
of naturally infected cats by reverse transcriptase PCR. J Clin Microbiol 33, 684-689. 
Herrewegh, A.A.P.M., Mähler, M., Hedrich, H.J., Haagmans, B.J., Egberink, H.F., 
Horzinek, M.C., Rottier, P.J.M. & de Groot, R.J. (1997). Persistence and evolution of 
feline coronavirus in a closed cat-breeding colony. Virology 234, 349-363. 
Hohdatsu, T., Okada, S., Ishizuka, Y., Yamada, H. & Koyama, H. (1992). The prevalence 
of types I and II feline coronavirus infections in cats. J Vet Med Sci 54, 557-562. 
Jacobse-Geels, H.E.L. & Horzinek, M.C. (1983). Expression of feline infectious peritonitis 
coronavirus antigens on the surface of feline macrophage-like cells. J Gen Virol 64, 1859-
1866. 
Kipar, A., Kremendahl, J., Addie, D.D., Leukert, W., Grant, C.K. & Reinacher, M. 
(1998). Fatal enteritis associated with coronavirus infection in cats. J Comp Path 119, 1-4. 
Kipar, A., Bellmann, S., Gunn-Moore, D., Leukert, W., Köhler, K., Menger, S. & 
Reinacher, M. (1999). Histopathological alterations of lymphatic tissues in cats without 
feline infectious peritonitis after long-term exposure to FIP virus. Vet Microbiol 69, 131-137. 
Kipar, A., Köhler, K., Leukert, W. & Reinacher, M. (2001). A comparison of lymphatic 
 24
tissues from cats without feline infectious peritonitis (FIP), cats with FIP virus infection but 
no FIP, and cats with no infection. J Comp Path 125, 182-191. 
Kipar, A., May, H., Menger, S., Weber, M., Leukert, W. & Reinacher, M. (2005). 
Morphological features and development of granulomatous vasculitis in feline infectious 
peritonitis. Vet Pathol 42, 321-330. 
Kummrow, M., Meli, M.L., Haessig, M., Goenczi, E., Poland, A., Pedersen, N.C., 
Hofmann-Lehmann, R. & Lutz, H. (2005). Feline coronavirus serotypes 1 and 2: 
seroprevalence and association with disease in Switzerland. Clin Diagn Lab Immunol 12, 
1209-1225. 
Leutenegger, C.M., Klein, D., Hofmann-Lehmann, R., Mislin, C., Hummel, U., Boni, J., 
Boretti, F., Guenzburg, W.H. & Lutz, H. (1999).  Rapid feline immunodeficiency virus 
provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time 
detection system. J Virol Meth 78, 105-116. 
Lin, C.-N., Su, B.-L., Wang, C.-H., Hsieh, M.-W., Chueh, T.-J., Chueh, L.-L. (2009). 
Genetic diversity and correlation with feline infectious peritonitis of feline coronavirus type I 
and II: A 5-year study in Taiwan. Vet Microbiol 136, 233-239. 
Meli, M., Kipar, A., Müller, C., Jenal, K., Gönczi, E.-E., Borel, N., Gunn-Moore, D., 
Chalmers, S., Lin, F., Reinacher, M. & Lutz, H. (2004). High viral loads despite absence 
of clinical and pathological findings in cats experimentally infected with feline coronavirus 
(FCoV) type I and in naturally FCoV-infected cats. J Fel Med Surg 6, 69-81. 
Pedersen, N.C. (1976). Morphological and physical characteristics of feline infectious 
peritonitis virus and its growth in autochthonous peritoneal cell cultures. Am J Vet Res 37, 
567-572.  
Pedersen, N.C. (1983). Feline infectious peritonitis and feline enteric coronavirus infections. 
Part I. Feline enteric coronaviruses. Fel Pract 13, 13-18.  
 25
Pedersen, N.C. (1995). An overview of feline enteric coronavirus and infectious peritonitis 
virus infections. Fel Pract 23, 7-21. 
Pedersen, N.C. (2009). A review of feline infectious peritonitis virus infection: 1963-2008. J 
Fel Med Surg 11, 225-258. 
Pedersen, N.C., Lin, H., Dodd, K.A. & Pesavento, P.A. (2009). Significance of coronavirus 
mutants in feces and diseased tissues of cats suffering from feline infectious peritonitis. 
Viruses 1, 166-184. 
Platt, A.M. & Mowat, A.M. (2008). Mucosal macrophages and the regulation of immune 
responses in the intestine. Immunol Lett 119, 22-31. 
Poland, A.M., Vennema, H., Foley, J.E. & Pedersen, N.C. (1996). Two related strains of 
feline infectious peritonitis virus isolated from immunocompromised cats infected with a 
feline enteric coronavirus. J Clin Microbiol 34, 3180-3184. 
Randolph, G.J., Inaba, K., Robbiani, D.F., Steinman, R.M. & Muller, W.A. (1999). 
Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 
11, 753-761. 
Sanchez-Cordon, P.J., Romero-Trevejo, J.L., Pedrera, M., Sanchez-Vizcaino, J.M., 
Bautista, M.J. & Gomez-Villamandos, J.C. (2008). Role of hepatic macrophages during 
the viral haemorrhagic fever induced by African Swine Fever virus. Histol Histopathol 23, 
683-691. 
Stoddart, C.A. & Scott, F.W. (1989). Intrinsic resistance of feline peritoneal macrophages 
to coronavirus infection correlates with in vivo virulence. J Virol 63, 436-440. 
Thanawongnuwech, R., Thacker, E.L. & Halbur, P.G. (1997). Effect of porcine 
reproductive and respiratory syndrome virus (PRRSV) (isolate ATCC VR-2385) infection on 
bactericidal activity of porcine pulmonary intravascular macrophages (PIMs): in vitro 
comparisons with pulmonary alveolar macrophages (PAMs). Vet Immunol Immunopathol 59, 
 26
323-335.  
Vennema, H., Poland, A., Foley, J. & Pedersen, N.C. (1998). Feline infectious peritonitis 
viruses arise by mutation from endemic feline enteric coronaviruses. Virology 243, 150-157. 
Vennema, H. (1999). Genetic shift and drift during feline coronavirus evolution. Vet 
Microbiol 69, 139-141. 
Zhang, Z. & Aleksandersen, S. (2004). Quantitative analysis of foot-and-mouth disease 





Table 1: Groups of cats, infectious doses and time points of euthanasia after oral infection 
with FCoV serotype I strains 
Cat Group 
and No. 
Virus strain  
and origin 
Infectious dose 
(RNA copy numbers) 
Day post infection 
of euthanasia 
1.1, 1.2 FCoVZu1 (FE*) 8 x 105 14 
2.1-2.3 FCoVZu1 (FE) 8 x 106 17 
3.1, 3.2 FCoVZu2 + Zu5 (FE*) 1 x 105 28 
4.1, 4.2 FCoVZu3 (FE*) 3 x 105 28 
5.1-5.15 FCoVZu1 (GH) 1.5 x 109 48 
6.1, 6.2 FCoVZu1 (GH) 3 x 109 80 
7.1, 7.2 FCoVZu1 (GH) 3 x 108 80 
8.1, 8.2 FCoVZu1 (GH) 3 x 107 80 
FE* - faecal extract from naturally infected cat; FE - faecal extract from experimentally 
infected cat; GH - gut homogenate (Meli et al., 2004) 
 28
Table 2: Correlation between viral shedding (faecal swabs, detection of FCoV by real-time 
RT-PCR) and the detection of FCoV RNA (real-time RT-PCR) in different intestinal 
compartments of FCoV serotype I infected, healthy cats at the day of euthanasia (14 to 80 
days post infection) 
Intestinal compartments positive for 
FCoV RNA (n) 
Faecal swab: 
FCoV RNA positive 
Faecal swab: 
FCoV RNA negative 
None (2) - 2 
Colon (12) 1 11 
Colon, jejunum (2) - 2 
Colon, ileum (2) - 2 
Colon, jejunum, ileum (3) 3 - 
Colon, duodenum, ileum (2) 2 - 




Fig. 1: Detection of FCoV RNA (real-time RT-PCR) in organs of FCoV serotype I infected, 
healthy cats sacrificed at different time points after infection (days 14, 17, 28, 48 and 80 post 
infection; post mortem tissue samples). 
 
Fig. 2: Average relative viral loads (in relation to GAPDH) in organs of healthy cats after 
experimental oral infection with FCoV type I strains for 14 to 80 days. A. Box and whisker 
plots demonstrating overall average relative viral loads in the different organs tested at 14 to 
80 days post infection. B. Box and whisker plots demonstrating overall average relative viral 
loads in selected organs at days 14, 17, 28, 48 and 80 after infection. Y-axis: Viral load 
relative to GAPDH. 
 
Fig. 3: Demonstration of FCoV antigen in organs of healthy SPF cats after oral infection with 
FCoV serotype I strains. A. Cat 5.2. Day 48 p.i.. Colon. Several intact superficial columnar 
epithelial cells express FCoV antigen (arrows). B, C. Cat 4.1. Day 28 p.i.. B. Mesenteric 
lymph node. Several sinus macrophages express FCoV antigen (arrows). C. Lung. Individual 
cells within capillaries (arrows; pulmonary intravascular macrophages) express FCoV 
antigen. Peroxidase anti-peroxidase method. Papanicolaou`s haematoxylin counterstain.  
 
 
 






